Literature DB >> 23580639

Factor VIIIa A2 subunit shows a high affinity interaction with factor IXa: contribution of A2 subunit residues 707-714 to the interaction with factor IXa.

Amy E Griffiths1, Ivan Rydkin, Philip J Fay.   

Abstract

Factor (F) VIIIa forms a number of contacts with FIXa in assembling the FXase enzyme complex. Surface plasmon resonance was used to examine the interaction between immobilized biotinylated active site-modified FIXa, and FVIII and FVIIIa subunits. The FVIIIa A2 subunit bound FIXa with high affinity (Kd = 3.9 ± 1.6 nm) that was similar to the A3C1C2 subunit (Kd = 3.6 ± 0.6 nm). This approach was used to evaluate a series of baculovirus-expressed, isolated A2 domain (bA2) variants where alanine substitutions were made for individual residues within the sequence 707-714, the C-terminal region of A2 thought to be FIXa interactive. Three of six bA2 variants examined displayed 2- to 4-fold decreased affinity for FIXa as compared with WT bA2. The variant bA2 proteins were also tested in two reconstitution systems to determine activity and affinity parameters in forming FXase and FVIIIa. Vmax values for all variants were similar to the WT values, indicating that these residues do not affect cofactor function. All variants showed substantially greater increases in apparent Kd relative to WT in reconstituting the FXase complex (8- to 26-fold) compared with reconstituting FVIIIa (1.3- to 6-fold) suggesting that the mutations altered interaction with FIXa. bA2 domain variants with Ala replacing Lys(707), Asp(712), and Lys(713) demonstrated the greatest increases in apparent Kd (17- to 26-fold). These results indicate a high affinity interaction between the FVIIIa A2 subunit and FIXa and show a contribution of several residues within the 707-714 sequence to this binding.

Entities:  

Keywords:  Coagulation Factors; Factor VIII; Mutagenesis; Protein Domains; Surface Plasmon Resonance (SPR)

Mesh:

Substances:

Year:  2013        PMID: 23580639      PMCID: PMC3663526          DOI: 10.1074/jbc.M113.456467

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  29 in total

1.  Cleavage of factor VIII heavy chain is required for the functional interaction of a2 subunit with factor IXA.

Authors:  P J Fay; M Mastri; M E Koszelak; H Wakabayashi
Journal:  J Biol Chem       Date:  2001-01-22       Impact factor: 5.157

2.  Cofactor activities of factor VIIIa and A2 subunit following cleavage of A1 subunit at Arg336.

Authors:  Mary E Koszelak Rosenblum; Kyla Schmidt; Jan Freas; Maria Mastri; Philip J Fay
Journal:  J Biol Chem       Date:  2002-01-17       Impact factor: 5.157

Review 3.  Activation of factor VIII and mechanisms of cofactor action.

Authors:  Philip J Fay
Journal:  Blood Rev       Date:  2004-03       Impact factor: 8.250

4.  Contribution of factor VIIIa A2 and A3-C1-C2 subunits to the affinity for factor IXa in factor Xase.

Authors:  P Vincent Jenkins; Julie L Dill; Qian Zhou; Philip J Fay
Journal:  Biochemistry       Date:  2004-05-04       Impact factor: 3.162

5.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

Authors:  M M Bradford
Journal:  Anal Biochem       Date:  1976-05-07       Impact factor: 3.365

6.  The role of phospholipid and factor VIIIa in the activation of bovine factor X.

Authors:  G van Dieijen; G Tans; J Rosing; H C Hemker
Journal:  J Biol Chem       Date:  1981-04-10       Impact factor: 5.157

7.  Stabilization of thrombin-activated porcine factor VIII:C by factor IXa phospholipid.

Authors:  P Lollar; G J Knutson; D N Fass
Journal:  Blood       Date:  1984-06       Impact factor: 22.113

8.  Bioengineering of coagulation factor VIII for efficient expression through elimination of a dispensable disulfide loop.

Authors:  S R Selvaraj; A N Scheller; H Z Miao; R J Kaufman; Steven W Pipe
Journal:  J Thromb Haemost       Date:  2012-01       Impact factor: 5.824

9.  Mutations associated with hemophilia A in the 558-565 loop of the factor VIIIa A2 subunit alter the catalytic activity of the factor Xase complex.

Authors:  P Vincent Jenkins; Jan Freas; Kyla M Schmidt; Qian Zhou; Philip J Fay
Journal:  Blood       Date:  2002-07-15       Impact factor: 22.113

10.  Phospholipid vesicle formation and transmembrane protein incorporation using octyl glucoside.

Authors:  L T Mimms; G Zampighi; Y Nozaki; C Tanford; J A Reynolds
Journal:  Biochemistry       Date:  1981-02-17       Impact factor: 3.162

View more
  5 in total

Review 1.  A Molecular Revolution in the Treatment of Hemophilia.

Authors:  John S S Butterfield; Kerry M Hege; Roland W Herzog; Radoslaw Kaczmarek
Journal:  Mol Ther       Date:  2019-11-13       Impact factor: 11.454

2.  Replacing the factor VIII C1 domain with a second C2 domain reduces factor VIII stability and affinity for factor IXa.

Authors:  Hironao Wakabayashi; Philip J Fay
Journal:  J Biol Chem       Date:  2013-09-12       Impact factor: 5.157

3.  Cofactor activity in factor VIIIa of the blood clotting pathway is stabilized by an interdomain bond between His281 and Ser524 formed in factor VIII.

Authors:  Hironao Wakabayashi; Morgan Monaghan; Philip J Fay
Journal:  J Biol Chem       Date:  2014-04-01       Impact factor: 5.157

4.  Factor VIIIa-mimetic cofactor activity of a bispecific antibody to factors IX/IXa and X/Xa, emicizumab, depends on its ability to bridge the antigens.

Authors:  Takehisa Kitazawa; Keiko Esaki; Tatsuhiko Tachibana; Shinya Ishii; Tetsuhiro Soeda; Atsushi Muto; Yoshiki Kawabe; Tomoyuki Igawa; Hiroyuki Tsunoda; Keiji Nogami; Midori Shima; Kunihiro Hattori
Journal:  Thromb Haemost       Date:  2017-04-28       Impact factor: 5.249

5.  SAXS analysis of the intrinsic tenase complex bound to a lipid nanodisc highlights intermolecular contacts between factors VIIIa/IXa.

Authors:  Kenneth C Childers; Shaun C Peters; Pete Lollar; Harold Trent Spencer; Christopher B Doering; Paul C Spiegel
Journal:  Blood Adv       Date:  2022-06-14
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.